Following the approval of Toripalimab by the Food and Drug Administration, two more Chinese-made cancer drugs have received approval for distribution in the US.
Following the approval of Toripalimab by the Food and Drug Administration, two more Chinese-made cancer drugs have received approval for distribution in the US.
How do they choose the names of these drugs? Do they just keep stringing together consonant-vowel-consonant-vowel until they hit some sort of limit?
Some of it may just be random. But there’s some logic to parts of it. I. This case the suffix -mab indicates that this drug is a monoclonal antibody.